Works matching IS 01145916 AND DT 2023 AND VI 46 AND IP 12
Results: 10
Long-Term Real-World Post-approval Safety Data of Multiple Biosimilars from One Marketing-Authorization Holder After More than 18 Years Since Their First Biosimilar Launch.
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1391, doi. 10.1007/s40264-023-01371-8
- By:
- Publication type:
- Article
Acknowledgement to Referees.
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1297, doi. 10.1007/s40264-023-01369-2
- Publication type:
- Article
The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs).
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1307, doi. 10.1007/s40264-023-01363-8
- By:
- Publication type:
- Article
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France.
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1381, doi. 10.1007/s40264-023-01359-4
- By:
- Publication type:
- Article
Sodium-Glucose Cotransporter 2 Inhibitor-Associated "Ketoacidosis" Versus "Diabetic Ketoacidosis": The Importance of Accurate Terminology.
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1303, doi. 10.1007/s40264-023-01358-5
- By:
- Publication type:
- Article
Pulmonary Toxicity Associated with Immune Checkpoint Inhibitors-Based Therapy: Current Perspectives and Future Directions.
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1313, doi. 10.1007/s40264-023-01357-6
- By:
- Publication type:
- Article
The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands.
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1323, doi. 10.1007/s40264-023-01356-7
- By:
- Publication type:
- Article
Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers.
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1363, doi. 10.1007/s40264-023-01355-8
- By:
- Publication type:
- Article
Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases.
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1353, doi. 10.1007/s40264-023-01354-9
- By:
- Publication type:
- Article
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 12, p. 1335, doi. 10.1007/s40264-023-01353-w
- By:
- Publication type:
- Article